USC comparison study of leading targeted therapies for a specific lung cancer could lead to better treatment decisions
Buddy Chung
In the largest real-world analysis of U.S. patients, researchers used insurance claims data to study the effectiveness of five drugs known as tyrosine kinase inhibitors to better understand differences in how the drugs affect patient outcomes. The post USC comparison study of leading targeted therapies for a specific lung cancer could lead to better treatment decisions appeared first on USC .